These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1890190)

  • 21. M-type 57 group A streptococcus bacteriocin.
    Simpson WJ; Tagg JR
    Can J Microbiol; 1983 Oct; 29(10):1445-51. PubMed ID: 6362811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Streptococcal Bacteriocin-Like Inhibitory Substances: Some Personal Insights into the Bacteriocin-Like Activities Produced by Streptococci Good and Bad.
    Tagg JR
    Probiotics Antimicrob Proteins; 2009 Jun; 1(1):60-6. PubMed ID: 26783132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bacteriocin-like inhibitory substance (BLIS) activity of Streptococcus macedonicus MBF10-2 and its synergistic action in combination with antibiotics.
    Grazia SE; Sumayyah S; Haiti FS; Sahlan M; Heng NCK; Malik A
    Asian Pac J Trop Med; 2017 Dec; 10(12):1140-1145. PubMed ID: 29268969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abiotrophia elegans strains comprise 8% of the nutritionally variant streptococci isolated from the human mouth.
    Sato S; Kanamoto T; Inoue M
    J Clin Microbiol; 1999 Aug; 37(8):2553-6. PubMed ID: 10405400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting of streptococci by zoocin A.
    Akesson M; Dufour M; Sloan GL; Simmonds RS
    FEMS Microbiol Lett; 2007 May; 270(1):155-61. PubMed ID: 17319876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial activity of a UV-stable bacteriocin-like inhibitory substance (BLIS) produced by Enterococcus faecium strain DSH20 against vancomycin-resistant Enterococcus (VRE) strains.
    Shokri D; Zaghian S; Khodabakhsh F; Fazeli H; Mobasherizadeh S; Ataei B
    J Microbiol Immunol Infect; 2014 Oct; 47(5):371-6. PubMed ID: 23838264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of a bacteriocin-like inhibitory substance from Carnobacterium piscicola against human and salmon isolates of Listeria monocytogenes.
    Schöbitz R; Suazo V; Costa M; Ciampi L
    Int J Food Microbiol; 2003 Jul; 84(2):237-44. PubMed ID: 12781946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutacin production by Streptococcus mutans may promote transmission of bacteria from mother to child.
    Grönroos L; Saarela M; Mättö J; Tanner-Salo U; Vuorela A; Alaluusua S
    Infect Immun; 1998 Jun; 66(6):2595-600. PubMed ID: 9596721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitory spectrum of a bacteriocinlike substance (mutacin) produced by some strains of Streptococcus mutans.
    Hamada S; Ooshima T
    J Dent Res; 1975; 54(1):140-5. PubMed ID: 1053754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human endocarditis due to nutritionally variant streptococci: streptococcus adjacens and Streptococcus defectivus.
    Bouvet A
    Eur Heart J; 1995 Apr; 16 Suppl B():24-7. PubMed ID: 7671920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bacteriocin-like inhibitory substances from Campylobacter spp.
    Workman SN; Been FE; Crawford SR; Lavoie MC
    Antonie Van Leeuwenhoek; 2008 May; 93(4):435-6. PubMed ID: 17955339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Microbiological and clinical studies of infective endocarditis due to nutritionally variant streptococci].
    Kikuchi K; Totsuka K; Shimizu K; Enari T; Shibata Y; Hasegawa H
    Kansenshogaku Zasshi; 1994 Jul; 68(7):830-6. PubMed ID: 8089548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activities of tigecycline against erythromycin-resistant Streptococcus pyogenes and Streptococcus agalactiae: mechanisms of macrolide and tetracycline resistance.
    Betriu C; Culebras E; Rodríguez-Avial I; Gómez M; Sánchez BA; Picazo JJ
    Antimicrob Agents Chemother; 2004 Jan; 48(1):323-5. PubMed ID: 14693558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new alkaline pH-adjusted medium enhances detection of beta-hemolytic streptococci by minimizing bacterial interference due to Streptococcus salivarius.
    Dierksen KP; Ragland NL; Tagg JR
    J Clin Microbiol; 2000 Feb; 38(2):643-50. PubMed ID: 10655361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bacteriocin production by Streptococcus milleri.
    Drucker DB; McKillop CM
    Can J Microbiol; 1982 Mar; 28(3):278-83. PubMed ID: 7083071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prevention of dental caries by BLIS-mediated inhibition of mutans streptococci.
    James SM; Tagg JR
    N Z Dent J; 1991 Jul; 87(389):80-3. PubMed ID: 1956623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Action of tomicide on bacterial cells. The bacteriostatic, bactericidal and bacteriolytic properties of tomicide].
    Blinkova LP; Butova LG; Elagina NI
    Antibiot Med Biotekhnol; 1985 Dec; 30(12):911-5. PubMed ID: 3909951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Applications of BLIS typing to studies of the survival on surfaces of salivary streptococci and staphylococci.
    Tagg JR; Ragland NL
    J Appl Bacteriol; 1991 Oct; 71(4):339-42. PubMed ID: 1960108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enocin: an antibiotic produced by Streptococcus salivarius that may contribute to protection against infections due to group A streptococci.
    Sanders CC; Sanders WE
    J Infect Dis; 1982 Nov; 146(5):683-90. PubMed ID: 6752297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of the bacteriolytic activity of nutritionally variant streptococci.
    Lampis G; Desogus A; Petruzzelli S; Laconi S; Ingianni A; Madeddu MA; Pompei R
    Anaerobe; 2007; 13(5-6):238-43. PubMed ID: 17889570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.